BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26251583)

  • 1. Prospective investigation of change in the prostate-specific antigens after various urologic procedures.
    Park SC; Shin YS; Zhang LT; Kim DS; Kim SZ; Park NC; Ahn TY; Kim JJ; Lee SW; So I; Park JK
    Clin Interv Aging; 2015; 10():1213-8. PubMed ID: 26251583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of investigative and operative procedures on serum prostate-specific antigen concentration.
    Dew T; Coker C; Saadeh F; Mulvin D; Coptcoat MJ; Sherwood RA
    Ann Clin Biochem; 1999 May; 36 ( Pt 3)():340-6. PubMed ID: 10376076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant transrectal ultrasound-guided biopsy and transurethral resection of prostate in patients with urinary retention and elevated serum prostate-specific antigen levels.
    Yang TY; Chow YC; Lin WR; Ko MC; Chen M; Chang HK; Hsu JM; Yang S; Lin WC; Chiu AW
    J Chin Med Assoc; 2016 Nov; 79(11):605-608. PubMed ID: 27344217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S; Cakar B; Conkbayir I; Hekimoglu B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ratio in clinical practice.
    Collins GN; Martin PJ; Wynn-Davies A; Brooman PJ; O'Reilly PH
    J Urol; 1997 May; 157(5):1744-7. PubMed ID: 9112518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration.
    Oesterling JE; Rice DC; Glenski WJ; Bergstralh EJ
    Urology; 1993 Sep; 42(3):276-82. PubMed ID: 7691013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
    Hara N; Koike H; Nobushita T; Miyajima N; Kawaguchi M; Nishiyama T; Takahashi K; Hohenfellner R
    Urol Oncol; 2010; 28(4):355-9. PubMed ID: 19110451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of prostate cancer with PSA < or =4.0 microg/L].
    Liu X; Tang J; Fei X; Li QY
    Zhonghua Nan Ke Xue; 2014 Mar; 20(3):234-8. PubMed ID: 24738460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of the role of transurethral resection of the prostate in patients with an elevated prostate-specific antigen level, minor lower urinary tract symptoms, and proven bladder outlet obstruction.
    van Renterghem K; Van Koeveringe G; Achten R; van Kerrebroeck P
    Eur Urol; 2008 Dec; 54(6):1385-92. PubMed ID: 18599187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of transrectal ultrasonography (TRUS) including digital rectal examination (DRE) of the prostate on the level of prostate specific antigen (PSA).
    Klomp ML; Hendrikx AJ; Keyzer JJ
    Br J Urol; 1994 Jan; 73(1):71-4. PubMed ID: 7507784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of transrectal ultrasound-guided biopsy of the prostate and transurethral resection of the prostate for detection of prostate cancer in patients with moderate lower urinary tract symptoms.
    Chen SS; Chiu LP; Chen KK
    J Chin Med Assoc; 2010 Nov; 73(11):568-72. PubMed ID: 21093824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of percent free PSA for prostate cancer detection in men with a total PSA of 4-10 ng/ml.
    Bermúdez-Tamayo C; Martín Martín JJ; González Mdel P; Pérez Romero C
    Urol Int; 2007; 79(4):336-44. PubMed ID: 18025853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prostate manipulation on the serum levels of complexed prostate-specific antigen and total prostate-specific antigen.
    Long R; Giri S; Diver S; Duddy L; McKeown D; Moran K
    Int J Urol; 2006 Jul; 13(7):947-50. PubMed ID: 16882060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could the sextant prostate biopsy be replaced by transurethral resection?
    Startsev VY; Pouline I; Gorelov S; Merkulova R
    Arch Ital Urol Androl; 2005 Dec; 77(4):194-8. PubMed ID: 16444931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship of the positive rate of TRUS guided prostatic biopsies with routine diagnostic findings in detecting prostate cancer].
    Ma H; Wan B
    Zhonghua Nan Ke Xue; 2013 Jan; 19(1):40-3. PubMed ID: 23469660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of transrectal ultrasonography of the prostate on serum prostate-specific antigen levels and free/total prostate-specific antigen ratio.
    Serel TA; Cetin M; Delibaş N; Celik E; Tahoğlu M
    Urol Int; 2000; 64(1):24-6. PubMed ID: 10782028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR.
    Moreno JG; O'Hara SM; Long JP; Veltri RW; Ning X; Alexander AA; Gomella LG
    Urology; 1997 Apr; 49(4):515-20. PubMed ID: 9111619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of transrectal ultrasound guided biopsy in patients over 70 years old with a prostate specific Antigen (PSA) level ≤ 15 ng/ml and normal digital rectal examination: a 10-year prospective follow-up study of 427 consecutive patients.
    Mohamed ZK; Dominguez-Escrig J; Vasdev N; Bharathan B; Greene D
    Urol Oncol; 2013 Nov; 31(8):1489-96. PubMed ID: 22591749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The electromagnetic detection of prostatic cancer: evaluation of diagnostic accuracy.
    Tubaro A; De Nunzio C; Trucchi A; Stoppacciaro A; Miano L
    Urology; 2008 Aug; 72(2):340-4. PubMed ID: 18336888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.